Using genetic perturbation and pharmacological inhibition, we aim to probe how interactions likely with CD44 may also potentiate adhesion of cancer cells on senescent peritoneal environments, after verifying if such interactions are crucial for the induction of senescence. The gene discussed is CD44; the disease is cancer.